|
|
|
Insider
Information: |
Debbane Raymond |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
5,279,044 |
|
Indirect Shares
|
5,451,204 |
|
|
Direct
Value |
$10,380,609 |
|
|
Indirect Value
|
$9,648,631 |
|
|
Total
Shares |
10,730,248 |
|
|
Total
Value |
$20,029,240 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
4
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
Percentage
Gain/Loss : |
31.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
WW International |
WW |
Former Director |
2023-05-09 |
134,387 |
|
0 |
Premium* |
|
Ehealth, Inc. |
EHTH |
10% Owner |
2006-10-18 |
262,445 |
2006-10-18 |
0 |
Premium* |
|
Lexicon Pharmaceuticals Inc |
LXRX |
Director |
2024-04-28 |
1,348,879 |
2024-04-28 |
5,451,204 |
Premium* |
|
Antigenics Inc |
AGEN |
10% Owner |
2008-05-10 |
3,533,333 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGEN |
Antigenics Inc |
10% Owner |
|
2008-05-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,533,333 |
|
- |
|
EHTH |
Ehealth, Inc. |
10% Owner |
|
2006-10-18 |
4 |
A |
$0.00 |
$0 |
D/D |
1,743,982 |
262,445 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
10% Owner |
|
2007-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,891,108 |
|
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
10% Owner |
|
2008-04-30 |
4 |
B |
$2.00 |
$1,338,104 |
I/I |
669,052 |
51,494,038 |
1.5 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
10% Owner |
|
2008-08-23 |
4 |
B |
$3.09 |
$205,473,107 |
I/I |
50,824,986 |
50,824,986 |
1.5 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
10% Owner |
|
2009-10-14 |
4 |
B |
$1.50 |
$20,158,886 |
I/I |
13,439,257 |
64,933,295 |
1.5 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
10% Owner |
|
2009-10-15 |
4 |
B |
$1.50 |
$3,023,832 |
I/I |
2,015,888 |
66,949,183 |
1.5 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
10% Owner |
|
2010-03-19 |
4 |
B |
$1.15 |
$108,410,737 |
I/I |
94,270,206 |
29,782,609 |
1.5 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2011-12-22 |
4 |
OE |
$1.13 |
$129,954,799 |
I/I |
115,004,247 |
5,553,292 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2012-10-23 |
4 |
B |
$2.25 |
$6,750,000 |
I/I |
3,000,000 |
283,154,744 |
2.25 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2013-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,101 |
21,865 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2014-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,820 |
34,685 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2014-12-10 |
4 |
B |
$0.90 |
$285,349 |
I/I |
315,896 |
30,098,505 |
2.25 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2014-12-12 |
4 |
B |
$0.88 |
$132,030 |
I/I |
150,000 |
30,248,505 |
2.25 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,691 |
53,376 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2016-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,432 |
9,057 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2017-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,281 |
10,338 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,564 |
12,902 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2019-09-13 |
4 |
B |
$2.25 |
$474,760 |
D/D |
197,473 |
210,375 |
2.39 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2019-09-13 |
4 |
B |
$2.46 |
$22,806 |
D/D |
9,269 |
219,644 |
2.39 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2019-09-16 |
4 |
B |
$2.60 |
$254,785 |
D/D |
93,773 |
313,417 |
2.39 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2020-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,466 |
316,883 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2021-04-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,638 |
327,521 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,024 |
331,545 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2022-08-01 |
4 |
B |
$2.50 |
$2,456,500 |
I/I |
982,600 |
5,303,814 |
2.1 |
% |
|
113 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|